Role of micro-RNAs 21, 124 and other novel biomarkers in distinguishing between group 1 WHO pulmonary hypertension and group 2, 3 WHO pulmonary hypertension

BACKGROUND: Pulmonary hypertension “PH” is considered a serious cardiovascular disease. World Health Organization divided PH into groups depending on many factors like pathological, hemodynamic, and clinical pictures. Lately, various micro-RNAs “miRNAs” and other novel biomarkers like endoglin and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimitry, Mark O., Soliman, Youssef M. A., ElKorashy, Reem I., Raslan, Hala M., Kamel, Solaf A., Hassan, Eman M., Ahmed, Fatma Elzahraa, Yousef, Rasha N., Awadallah, Eman A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468479/
https://www.ncbi.nlm.nih.gov/pubmed/37646902
http://dx.doi.org/10.1186/s43044-023-00395-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468479/
https://www.ncbi.nlm.nih.gov/pubmed/37646902
http://dx.doi.org/10.1186/s43044-023-00395-w

Ejemplares similares